Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Allon neurology news

    Allon Therapeutics Inc. (TSX:NPC), Vancouver, B.C. Business: Neurology Allon said its trustee Deloitte & Touche Inc. received an unsolicited offer from an undisclosed third party to acquire Allon. Allon said Deloitte is…

    Published on 6/17/2013
  • Amneal Pharmaceuticals, Hanmi Pharmaceutical, AstraZeneca generics, gastrointestinal news

    Amneal Pharmaceuticals LLC, Bridgewater, N.J. Hanmi Pharmaceutical Co. Ltd. (KOSDAQ:128940), Seoul, South Korea AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Generics, Gastrointestinal The companies …

    Published on 6/17/2013
  • Boehringer Ingelheim biomanufacturing news

    Boehringer Ingelheim GmbH, Ingelheim, Germany Business: Biomanufacturing Boehringer will invest over 35 million ($46.2 million) to build a cGMP biopharmaceuticals facility in Shanghai. The site, which will utilize …

    Published on 6/17/2013
  • Bristol-Myers pharmaceuticals news

    Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Pharmaceuticals Robert Ramnarine, formerly assistant treasurer for capital markets at Bristol-Myers, pled guilty to securities fraud in the U.S. District …

    Published on 6/17/2013
  • Cornerstone Therapeutics, Exela PharmSci Inc. cardiovascular news

    Cornerstone Therapeutics Inc. (NASDAQ:CRTX), Cary, N.C. Exela PharmSci Inc., Reston, Va. Business: Cardiovascular Cornerstone received a Paragraph IV notification letter from Exela PharmaSci's Exela Pharma Sciences LLC…

    Published on 6/17/2013
  • Dana Farber Cancer Institute, The Leukemia and Lymphoma Society (LLS) cancer news

    Dana Farber Cancer Institute, Boston, Mass. The Leukemia and Lymphoma Society (LLS), White Plains, N.Y. Business: Cancer The cancer organizations partnered to establish the Blood Cancer Research Partnership (BCRP) …

    Published on 6/17/2013
  • Duke University, National Institutes of Health infectious news

    Duke University, Durham, N.C. National Institutes of Health, Bethesda, Md. Business: Infectious The university received $2 million from NIH's National Institute of Allergy and Infectious Diseases (NIAID) to initiate a …

    Published on 6/17/2013
  • Florida Legislature, Oregon State Legislature biosimilars news

    Florida Legislature, Tallahassee, Fla. Oregon State Legislature, Salem, Ore. Business: Biosimilars Florida Governor Rick Scott and Oregon Governor John Kitzhaber separately signed state laws related to the …

    Published on 6/17/2013
  • Forest Laboratories pharmaceuticals news

    Forest Laboratories Inc. (NYSE:FRX), New York, N.Y. Business: Pharmaceuticals Forest named Vincent Intrieri a director as part of a deal with activist investor Carl Icahn to avoid a proxy contest for the third straight …

    Published on 6/17/2013
  • Genentech, PDL BioPharma, Roche cancer news

    Genentech Inc., South San Francisco, Calif. PDL BioPharma Inc. (NASDAQ:PDLI), Incline Village, Nev. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Cancer PDL filed a notice of arbitration against Roche's …

    Published on 6/17/2013
  • Gilead, Roche infectious news

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Infectious Gilead disclosed in an SEC filing that it submitted in April a response to arbitration …

    Published on 6/17/2013
  • GlaxoSmithKline autoimmune news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Autoimmune GlaxoSmithKline said Jingwu Zang, SVP and head of R&D China, has been dismissed after an internal investigation revealed "wrongly characterized…

    Published on 6/17/2013
  • InterMune pulmonary news

    InterMune Inc. (NASDAQ:ITMN), Brisbane, Calif. Business: Pulmonary The SEC said it reached a settlement with Bruce Tomlinson, former VP of finance, principal accounting officer and controller at InterMune, after the …

    Published on 6/17/2013
  • Maxygen hematology, other news

    Maxygen Inc. (NASDAQ:MAXY), San Mateo, Calif. Business: Hematology, Other Maxygen said its board approved a plan to liquidate and dissolve the company. The estimated shareholder payout is about $68.2-$69.6 million, or …

    Published on 6/17/2013
  • Med BioGene diagnostic news

    Med BioGene Inc. (TSX-V:MBI), Vancouver, B.C. Business: Diagnostic Diagnostic company Med BioGene said that four shareholders filed a petition in the British Columbia Supreme Court. The petition makes claims against the…

    Published on 6/17/2013
  • Myriad Genetics, American Civil Liberties Union (ACLU) diagnostic news

    Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah American Civil Liberties Union (ACLU), New York, N.Y. Business: Diagnostic The U.S. Supreme Court unanimously ruled that isolated DNA cannot be patented but cDNA …

    Published on 6/17/2013
  • Neumedicines, U.S. Department of Health and Human Services (HHS) other news

    Neumedicines Inc., Pasadena, Calif. U.S. Department of Health and Human Services (HHS), Washington, D.C. Business: Other Neumedicines said it received $8.3 million in funding from HHS's Biomedical Advanced Research and …

    Published on 6/17/2013
  • NovaMedica, S. Fyodorov Eye Microsurgery Complex Federal State Institution ophthalmic news

    NovaMedica, Moscow, Russia S. Fyodorov Eye Microsurgery Complex Federal State Institution, Moscow, Russia Business: Ophthalmic NovaMedica and the institution partnered to jointly examine the Russian ophthalmology market…

    Published on 6/17/2013
  • Proteostasis, The Michael J. Fox Foundation for Parkinson's Research (MJFF) neurology news

    Proteostasis Therapeutics Inc., Cambridge, Mass. The Michael J. Fox Foundation for Parkinson's Research (MJFF), New York, N.Y. Business: Neurology Proteostasis said it received an undisclosed grant from the foundation …

    Published on 6/17/2013
  • Sun Pharmaceutical, Teva, Pfizer, Takeda gastrointestinal news

    Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE: SUNPHARMA), Mumbai, India Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Pfizer Inc. (NYSE:PFE), New York, N.Y. Takeda Pharmaceutical Co. Ltd. (…

    Published on 6/17/2013
  • Teva genitourinary news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Genitourinary The Department of Justice said FDA will make Plan B One-Step levonorgestrel, a single-dose formulation emergency contraceptive…

    Published on 6/17/2013
  • Allon, Paladin neurology news

    Allon Therapeutics Inc. (TSX:NPC), Vancouver, B.C. Paladin Labs Inc. (TSX:PLB), Montreal, Quebec Business: Neurology Paladin proposed to purchase all issued and outstanding shares of Allon for C$1 per share, or about C$…

    Published on 6/10/2013
  • AstraZeneca, Michael J. Fox Foundation for Parkinson's Research neurology news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Michael J. Fox Foundation for Parkinson's Research, New York, N.Y. Business: Neurology AstraZeneca received a $465,000 grant from the foundation to support research on …

    Published on 6/10/2013
  • Aveo Pharmaceuticals cancer news

    Aveo Pharmaceuticals Inc. (NASDAQ:AVEO), Cambridge, Mass. Business: Cancer Aveo will reduce headcount by 140 (62%) to about 86 to focus resources on clinical development of tivozanib for colorectal and breast cancer. …

    Published on 6/10/2013
  • Bill & Melinda Gates Foundation infectious news

    Bill & Melinda Gates Foundation, Seattle, Wash. Business: Infectious The Bill & Melinda Gates Foundation awarded $8.1 million in grants under Round 10 of its Grand Challenges Explorations (GCE) initiative. The …

    Published on 6/10/2013

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993